Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126994691 | 12699469 | 1 | I | 20090427 | 20090501 | 20160830 | 20160830 | EXP | US-PFIZER INC-2009206715 | PFIZER | 70.00 | YR | F | Y | 96.15000 | KG | 20160830 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126994691 | 12699469 | 1 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | UNK | Y | U | 0 | TABLET | |||||||
| 126994691 | 12699469 | 2 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | UNK | 18667 | ||||||||||
| 126994691 | 12699469 | 3 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | UNK | 74133 | ||||||||||
| 126994691 | 12699469 | 4 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | UNK, 1X/DAY | 0 | QD | |||||||||
| 126994691 | 12699469 | 5 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | UNK | 0 | ||||||||||
| 126994691 | 12699469 | 6 | C | BRIMONIDINE TARTRATE. | BRIMONIDINE TARTRATE | 1 | Ophthalmic | UNK | 0 | ||||||||||
| 126994691 | 12699469 | 7 | C | TRAVATAN | TRAVOPROST | 1 | Ophthalmic | UNK | 0 | ||||||||||
| 126994691 | 12699469 | 8 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 126994691 | 12699469 | 9 | C | TYLENOL ARTHRITIS PAIN | ACETAMINOPHEN | 1 | Oral | UNK | 0 | ||||||||||
| 126994691 | 12699469 | 10 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | Oral | UNK | 0 | ||||||||||
| 126994691 | 12699469 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | UNK | 0 | ||||||||||
| 126994691 | 12699469 | 12 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Oral | UNK | 0 | ||||||||||
| 126994691 | 12699469 | 13 | C | VITAMIN C | ASCORBIC ACID | 1 | Oral | UNK | 0 | ||||||||||
| 126994691 | 12699469 | 14 | C | GARLIC. | GARLIC | 1 | Oral | UNK | 0 | ||||||||||
| 126994691 | 12699469 | 15 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126994691 | 12699469 | 1 | Osteoarthritis |
| 126994691 | 12699469 | 2 | Hypertension |
| 126994691 | 12699469 | 3 | Hypertension |
| 126994691 | 12699469 | 4 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126994691 | 12699469 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126994691 | 12699469 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126994691 | 12699469 | 1 | 20080702 | 20120118 | 0 | |
| 126994691 | 12699469 | 2 | 2007 | 0 | ||
| 126994691 | 12699469 | 3 | 2005 | 0 | ||
| 126994691 | 12699469 | 4 | 20080702 | 0 | ||
| 126994691 | 12699469 | 5 | 2006 | 0 | ||
| 126994691 | 12699469 | 6 | 2004 | 0 | ||
| 126994691 | 12699469 | 7 | 2004 | 0 | ||
| 126994691 | 12699469 | 8 | 2007 | 0 | ||
| 126994691 | 12699469 | 9 | 200806 | 0 | ||
| 126994691 | 12699469 | 10 | 2002 | 0 | ||
| 126994691 | 12699469 | 11 | 2002 | 0 | ||
| 126994691 | 12699469 | 12 | 2002 | 0 | ||
| 126994691 | 12699469 | 13 | 2002 | 0 | ||
| 126994691 | 12699469 | 14 | 2002 | 0 | ||
| 126994691 | 12699469 | 15 | 2002 | 0 |